The exome and untranslated regulatory regions (UTRs) comprise only 1-2% of the human genome, yet house as many as 85% of disease-related mutations. As a research tool, exome sequencing is a powerful way to investigate common and rare genetic variations that play an important role in complex human diseases.
GENEWIZ provides complete solutions for exome sequencing projects from experimental design through advanced bioinformatics analysis.
CLIA-compliant whole exome sequencing (WES) is also available for clinical researchers.
GENEWIZ accepts purified genomic DNA, frozen cell pellets as starting material for Exome Sequencing projects. We also accept formalin-fixed, paraffin-embedded (FFPE) thin tissue sections (slides) for Exome sequencing services. For detailed sample submission requirements please visit our Sample Submission Guidelines page.
GENEWIZ is a certified service provider for Illumina NGS platforms. For information on our NGS platforms as well as recommended configurations for your projects, please visit the NGS Platforms page.